Qube Research & Technologies (QRT)’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $9.3M | Buy |
343,897
+55,628
| +19% | +$1.87M | 0.01% | 1319 |
|
|
2025
Q4 | $12.3M | Sell |
288,269
-72,697
| -20% | -$2.74M | 0.02% | 1209 |
|
|
2025
Q3 | $10.2M | Buy |
360,966
+189,542
| +111% | +$5.67M | 0.01% | 1313 |
|
|
2025
Q2 | $3.21M | Buy |
171,424
+16,807
| +11% | +$319K | ﹤0.01% | 1962 |
|
|
2025
Q1 | $2.78M | Buy |
154,617
+36,660
| +31% | +$744K | ﹤0.01% | 1826 |
|
|
2024
Q4 | $1.98M | Buy |
+117,957
| New | +$2.26M | ﹤0.01% | 1884 |
|
|
2024
Q3 | – | Sell |
-17,667
| Closed | -$145K | – | 3987 |
|
|
2024
Q2 | $145K | Buy |
17,667
+8,596
| +95% | +$90K | ﹤0.01% | 2518 |
|
|
2024
Q1 | $134K | Buy |
+9,071
| New | +$122K | ﹤0.01% | 3196 |
|
|
2023
Q4 | – | Sell |
-12,433
| Closed | -$134K | – | 4681 |
|
|
2023
Q3 | $134K | Sell |
12,433
-2,648
| -18% | -$31.9K | ﹤0.01% | 2560 |
|
|
2023
Q2 | $195K | Sell |
15,081
-32,256
| -68% | -$436K | ﹤0.01% | 1788 |
|
|
2023
Q1 | $625K | Buy |
+47,337
| New | +$752K | ﹤0.01% | 1478 |
|
|
2022
Q4 | – | Sell |
-57,661
| Closed | -$680K | – | 2909 |
|
|
2022
Q3 | $680K | Buy |
+57,661
| New | +$780K | ﹤0.01% | 1351 |
|
|
2022
Q2 | – | Sell |
-11,201
| Closed | -$335K | – | 3033 |
|
|
2022
Q1 | $335K | Buy |
11,201
+919
| +9% | +$24.9K | ﹤0.01% | 1726 |
|
|
2021
Q4 | $272K | Sell |
10,282
-863
| -8% | -$26K | ﹤0.01% | 1848 |
|
|
2021
Q3 | $405K | Buy |
11,145
+9,208
| +475% | +$362K | 0.01% | 1331 |
|
|
2021
Q2 | $84K | Sell |
1,937
-7,182
| -79% | -$271K | ﹤0.01% | 1972 |
|
|
2021
Q1 | $312K | Buy |
9,119
+4,975
| +120% | +$197K | 0.01% | 1437 |
|
|
2020
Q4 | $145K | Buy |
+4,144
| New | +$120K | ﹤0.01% | 1591 |
|
Other funds holding RIGL
AC
VCM
